已收盘 05-08 16:00:00 美东时间
+0.090
+2.27%
The US FDA has granted orphan drug designation to Neurocrine Biosciences' (NBIX) NBIB-223 (frataxin) for the treatment of Friedreich ataxia. Therapies with orphan status have a potential seven years o...
05-08 00:54
Voyager Therapeutics (VYGR) announced on Tuesday in an SEC Form 8-K filing that its CFO, Nathan Jorgensen, has resigned, effective May 8, 2026, to take up a new opportunity. The Board has appointed Ro...
04-22 04:56
Voyager Therapeutics ( ($VYGR) ) has shared an update. On April 15, 2026, Voyag...
04-22 04:40
https://www.sec.gov/ix?doc=/Archives/edgar/data/1640266/000110465926045997/tm2612325d1_8k.htm
04-22 04:38
Amazon launches AI research tool to speed early-stage drug discovery By Sahil Pandey and Puyaan Singh April 14 (Reuters) - Amazon's AMZN.O cloud unit on Tuesday launched Amazon Bio Discovery, an artificial intelligence application designed to speed early-stage drug discovery by allowing scientists
04-14 22:31
今日重点评级关注:韦德布什:维持Black Diamond Therapeutic"跑赢大市"评级,目标价从13美元升至14美元;花旗:维持Olema Pharmaceuticals"买入"评级,目标价从60美元升至62美元
03-18 10:48
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Voyager Therapeutics (NASDAQ:VYGR) with a Buy and maintains $25 price target.
03-18 01:35
VYGR飙升21%,Q4亏损收窄及销售额超预期;Figure大涨超20%,进军汽车贷款市场获华尔街唱多;Stagwell涨逾17%,引入AppLovin先进的移动广告平台>>
03-11 16:04
Voyager Therapeutics shares are trading higher after the company reported bette...
03-11 00:26
Voyager Therapeutics (NASDAQ:VYGR) released its Q4 earnings on Monday, March 9,...
03-10 04:04